摘要
为定量控制降糖药达格列净中的杂质,对达格列净中的2个杂质5-溴-2-氯-2′-乙氧基二苯甲酮(1)和5-溴-2-氯-2′-乙氧基二苯甲烷(2)进行了定向合成,以5-溴-2-氯苯甲酸和苯酚经缩合、Fries重排,然后乙基化得到杂质1,杂质1再经还原得到杂质2。其结构经核磁共振氢谱和质谱确证结构。
To perform the quality control of dapagliflozin, two impurities of dapagliflozin including 5-bromo-2-chlorophenyl-2′-ethoxyldiphenylmethanone(1) and 5-bromo-2-chloro-2′-ethoxyl diphenylmethane(2) were synthesized. Impurity 1 was prepared via condensation, Fries rearrangement and ethylation using 5-bromo-2-chlorobenzoic acid and phenol as the starting materials. Impurity 2 was obtained from reduction of impurity 1.The structures of Impurity 1 and Impurity 2 were characterized using1 H NMR and MS.
出处
《精细化工中间体》
CAS
2016年第3期24-27,共4页
Fine Chemical Intermediates
基金
国家"重大新药创制"科技重大专项(2009ZX09301-012)
关键词
达格列净
杂质
合成
dapagliflozin
impurity
synthesis